litlas
Log inCreate account

Jerry Avorn

Active 1982–2025

215
Papers
44,349
Citations
121
h-index
211
i10-index

Citations

Citations per year for Jerry Avorn1936: 1 citations1960: 1 citations1976: 1 citations1981: 2 citations1983: 7 citations1984: 4 citations1985: 4 citations1986: 7 citations1987: 27 citations1988: 12 citations1989: 29 citations1990: 45 citations1991: 25 citations1992: 35 citations1993: 46 citations1994: 45 citations1995: 56 citations1996: 82 citations1997: 61 citations1998: 79 citations1999: 77 citations2000: 88 citations2001: 126 citations2002: 128 citations2003: 164 citations2004: 270 citations2005: 283 citations2006: 301 citations2007: 349 citations2008: 385 citations2009: 380 citations2010: 425 citations2011: 367 citations2012: 371 citations2013: 320 citations2014: 322 citations2015: 363 citations2016: 324 citations2017: 340 citations2018: 258 citations2019: 953 citations2020: 954 citations2021: 778 citations2022: 588 citations2023: 368 citations2024: 622 citations2025: 272 citations2026: 14 citations1937–1959: no citations, so these years are not shown1961–1975: no citations, so these years are not shown1977–1980: no citations, so these years are not shown1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,155 citing papers, 38.9% of this breakdownUnited Kingdom: 1,064 citing papers, 8% of this breakdownCanada: 947 citing papers, 7.1% of this breakdownAustralia: 459 citing papers, 3.5% of this breakdownGermany: 434 citing papers, 3.3% of this breakdownItaly: 407 citing papers, 3.1% of this breakdownNetherlands: 407 citing papers, 3.1% of this breakdownChina: 375 citing papers, 2.8% of this breakdownFrance: 326 citing papers, 2.4% of this breakdownSpain: 266 citing papers, 2% of this breakdownSweden: 242 citing papers, 1.8% of this breakdownDenmark: 234 citing papers, 1.8% of this breakdown
0%38.9%Other 22.2%

Institutions

Fields

  • Medicine65.8%
  • Health Professions6.5%
  • Economics, Econometrics and Finance4.8%
  • Pharmacology, Toxicology and Pharmaceutics4.4%
  • Biochemistry, Genetics and Molecular Biology4.1%
  • Mathematics2.7%
  • Other11.7%

Topics

  • Medication Adherence and Compliance3.9%
  • Pharmaceutical Practices and Patient Outcomes3.5%
  • Health Systems, Economic Evaluations, Quality of Life2.9%
  • Pharmaceutical Economics and Policy1.9%
  • Chronic Disease Management Strategies1.5%
  • Rheumatoid Arthritis Research and Therapies1.5%
  • Other84.8%

Coauthors

All papers

Open in search
  1. Variable Selection for Propensity Score Models

    Authors: M. Alan Brookhart, Sebastian Schneeweiß, Kenneth J. Rothman, Robert J. Glynn, Jerry Avorn, Til Stürmer‎ - American Journal of Epidemiology 2006 cited by 2,317

  2. Measuring Frailty in Medicare Data: Development and Validation of a Claims-Based Frailty Index

    Authors: Dae Hyun Kim, Sebastian Schneeweiß, Robert J. Glynn, Lewis A. Lipsitz, Kenneth Rockwood, Jerry Avorn - The Journals of Gerontology Series A 2017 cited by 603

  3. A combined comorbidity score predicted mortality in elderly patients better than existing scores

    Authors: Joshua J. Gagne, Robert J. Glynn, Jerry Avorn, Raisa Levin, Sebastian Schneeweiß - Journal of Clinical Epidemiology 2011 cited by 1,004

  4. High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data

    Authors: Sebastian Schneeweiß, Jeremy A. Rassen, Robert J. Glynn, Jerry Avorn, Helen Mogun, M. Alan Brookhart - Epidemiology 2009 cited by 1,148

  5. FDA Approval and Regulation of Pharmaceuticals, 1983-2018

    Authors: Jonathan J. Darrow, Jerry Avorn, Aaron S. Kesselheim - JAMA 2020 cited by 362

  6. FDA Regulation and Approval of Medical Devices: 1976-2020

    Authors: Jonathan J. Darrow, Jerry Avorn, Aaron S. Kesselheim - JAMA 2021 cited by 167

  7. Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study

    Authors: Dae Hyun Kim, Robert J. Glynn, Jerry Avorn, Lewis A. Lipsitz, Kenneth Rockwood, Ajinkya Pawar, Sebastian Schneeweiß - The Journals of Gerontology Series A 2018 cited by 266

  8. A review of uses of health care utilization databases for epidemiologic research on therapeutics

    Authors: Sebastian Schneeweiß, Jerry Avorn - Journal of Clinical Epidemiology 2005 cited by 1,270

  9. The 2.6 Billion Pill — Methodologic and Policy Considerations

    Authors: Jerry Avorn - New England Journal of Medicine 2015 cited by 324

  10. Full Coverage for Preventive Medications after Myocardial Infarction

    Authors: Niteesh K. Choudhry, Jerry Avorn, Robert J. Glynn, Elliott M. Antman, Sebastian Schneeweiß, Michele Toscano, Lonny Reisman, Joaquim Fernandes, Claire M. Spettell, Joy Lee, Raisa Levin, Troyen A. Brennan, William H. Shrank - New England Journal of Medicine 2011 cited by 741

  11. Antidepressant Use in Pregnancy and the Risk of Cardiac Defects

    Authors: Krista F. Huybrechts, Kristin Palmsten, Jerry Avorn, Lee S. Cohen, Lewis B. Holmes, Jessica M. Franklin, Helen Mogun, Raisa Levin, Mary K. Kowal, Soko Setoguchi, Sonia Hernández–Dı́az - New England Journal of Medicine 2014 cited by 406

  12. US public investment in development of mRNA covid-19 vaccines: retrospective cohort study

    Authors: Hussain S. Lalani, Sarosh Nagar, Ameet Sarpatwari, Rachel E. Barenie, Jerry Avorn, Benjamin N. Rome, Aaron S. Kesselheim - BMJ 2023 cited by 84

  13. The High Cost of Prescription Drugs in the United States

    Authors: Aaron S. Kesselheim, Jerry Avorn, Ameet Sarpatwari - JAMA 2016 cited by 582

  14. Accuracy of medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records

    Authors: Yuka Kiyota, Sebastian Schneeweiß, Robert J. Glynn, Carolyn C. Cannuscio, Jerry Avorn, Daniel H. Solomon - American Heart Journal 2004 cited by 525

  15. Treatment Effects in the Presence of Unmeasured Confounding: Dealing With Observations in the Tails of the Propensity Score Distribution-A Simulation Study

    Authors: Til Stürmer‎, Kenneth J. Rothman, Jerry Avorn, Robert J. Glynn - American Journal of Epidemiology 2010 cited by 451

  16. Statins and congenital malformations: cohort study

    Authors: Brian T. Bateman, Sonia Hernández–Dı́az, Michael A. Fischer, Ellen W. Seely, Jeffrey L. Ecker, Jessica M. Franklin, Rishi Desai, C. Allen-Coleman, Helen Mogun, Jerry Avorn, Krista F. Huybrechts - BMJ 2015 cited by 232

  17. Risk of Death in Elderly Users of Conventional vs. Atypical Antipsychotic Medications

    Authors: Philip S. Wang, Sebastian Schneeweiß, Jerry Avorn, Michael A. Fischer, Helen Mogun, Daniel Solomon, M. Alan Brookhart - New England Journal of Medicine 2005 cited by 959

  18. Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer

    Authors: Ann H. Partridge, Philip S. Wang, Eric P. Winer, Jerry Avorn - Journal of Clinical Oncology 2003 cited by 680

  19. A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods

    Authors: Til Stürmer‎, Manisha Joshi, Robert J. Glynn, Jerry Avorn, Kenneth J. Rothman, Sebastian Schneeweiß - Journal of Clinical Epidemiology 2005 cited by 669

  20. Patterns of cardiovascular risk in rheumatoid arthritis

    Authors: David H. Solomon, Nicola Goodson, J.N. Katz, M. Weinblatt, Jerry Avorn, Soko Setoguchi, Christine Canning, Sebastian Schneeweiß - Annals of the Rheumatic Diseases 2006 cited by 415

  21. Adherence to Lipid-lowering Therapy and the Use of Preventive Health Services: An Investigation of the Healthy User Effect

    Authors: M. Alan Brookhart, A. R. Patrick, Colin R. Dormuth, Jerry Avorn, William H. Shrank, Suzanne M. Cadarette, David H. Solomon - American Journal of Epidemiology 2007 cited by 380

  22. Electronic Medication Packaging Devices and Medication Adherence

    Authors: Kyle D. Checchi, Krista F. Huybrechts, Jerry Avorn, Aaron S. Kesselheim - JAMA 2014 cited by 203

  23. Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov

    Authors: Laura E. Bothwell, Jerry Avorn, Nazleen F. Khan, Aaron S. Kesselheim - BMJ Open 2018 cited by 192

  24. Making the Case for Accelerated Withdrawal of Aducanumab

    Authors: Peter J. Whitehouse, Sam Gandy, Vikas Saini, Daniel R. George, Eric B. Larson, G. Caleb Alexander, Jerry Avorn, Shannon Brownlee, Cameron J. Camp, Howard Chertkow, Adriane Fugh‐Berman, Robert Howard, Aaron S. Kesselheim, Kenneth M. Langa, George Perry, Edo Richard, Lon S. Schneider - Journal of Alzheimer s Disease 2022 cited by 40